Psoriasis vulgaris in patients with a recent history of neoplasia: safety of interleukin-23 inhibitors. A multicentre retrospective study

Our real-life experience is the largest study investigating the use of anti-IL-23 agents and the risk of cancer recurrence, progression and development in patients with a history of cancer. This study confirms their safety also in this cohort of patients.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Dermatology
Published
2025-06-16
DOI
https://doi.org/10.1093/ced/llaf184
Citations
3
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
2.39
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Psoriasis vulgaris in patients with a recent history of neoplasia: safety of interleukin-23 inhibitors. A multicentre retrospective study

Luca Mastorino, Angelo Valerio Marzano, Marco Manfredini, Anna Elisabetta Cagni et al.
3 citations
Clinical and Experimental Dermatology
Psoriasis: Treatment and Pathogenesis
2.39
article

Psoriasis vulgaris in patients with a recent history of neoplasia: safety of interleukin-23 inhibitors. A multicentre retrospective study

Luca Mastorino, Angelo Valerio Marzano, Marco Manfredini, Anna Elisabetta Cagni, Maria Esposito, Matteo Megna, Emanuele Trovato, Claudio Feliciani, Emanuele Cozzani, Claudia Lasagni, Francesca Peccerillo, Silvia Gerosa, Paolo Amerio, Martina Burlando, Vito Giuseppe Di Lernia, Pietro Quaglino, Riccardo Balestri, Andrea Carugno, Francesca Satolli, Marco Romanelli, Alessandra Narcisi, Alexandra Maria Giovanna Brunasso, Marco Brusasco, Giulia Rech, Maria Concetta Fargnoli, Carlo Giovanni Carrera
article en
3 citations

Abstract

Our real-life experience is the largest study investigating the use of anti-IL-23 agents and the risk of cancer recurrence, progression and development in patients with a history of cancer. This study confirms their safety also in this cohort of patients.

Clinical and Experimental DermatologyVol. 50(9)
University of Parma (IT)
Good health and well-being
Openalex Percentile: Top 11%
Psoriasis: Treatment and Pathogenesis
2.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.